GALMED PHARMACEUTICALS LTD. (EOCN) Net margin 2016–2018
GALMED PHARMACEUTICALS LTD. (EOCN) net profit margin by fiscal year — reported net income divided by reported revenue.
-483.6%FY2018 · since FY2016: -3630.2% → -483.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | -483.6% | +649.9 pp |
| FY2017 | -1133.5% | +2496.6 pp |
| FY2016 | -3630.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More EOCN financial trends
EOCN RevenueEOCN Net incomeEOCN Gross profitEOCN Gross marginEOCN Operating incomeEOCN Operating marginEOCN Operating cash flowEOCN Free cash flowEOCN Capital expendituresEOCN Return on equityEOCN Stock buybacksEOCN Dividends paidEOCN Total assetsEOCN Total liabilitiesEOCN Shareholders’ equityEOCN overview →